Ken Fisher's IBB Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 2,200 shares of iShares Biotechnology ETF (IBB) worth $317,614, representing 0.00% of the portfolio. First purchased in 2016-Q3, this long-term strategic position has been held for 37 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in IBB, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2018, adding 5,772 shares. Largest reduction occurred in Q3 2019, reducing 8,681 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's iShares Biotechnology ETF (IBB) Holding Value Over Time
Track share changes against reported price movement
Quarterly iShares Biotechnology ETF (IBB) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2016 | +1,417 | New Buy | 1,417 | $289.34 |
| Q4 2016 | -609 | Reduce 42.98% | 808 | $264.85 |
| Q1 2017 | -808 | Sold Out | 808 | $264.85 |
| Q2 2017 | +2,150 | New Buy | 2,150 | $310.23 |
| Q3 2017 | +826 | Add 38.42% | 2,976 | $333.67 |
| Q4 2017 | +120 | Add 4.03% | 3,096 | $106.91 |
| Q1 2018 | -388 | Reduce 12.53% | 2,708 | $106.72 |
| Q2 2018 | -2,708 | Sold Out | 2,708 | $106.72 |
| Q3 2018 | +1,887 | New Buy | 1,887 | $121.89 |
| Q4 2018 | +5,772 | Add 305.88% | 7,659 | $96.49 |
| Q1 2019 | -7,659 | Sold Out | 7,659 | $96.49 |
| Q2 2019 | +11,072 | New Buy | 11,072 | $109.10 |
| Q3 2019 | -8,681 | Reduce 78.40% | 2,391 | $99.54 |
| Q4 2019 | +2,946 | Add 123.21% | 5,337 | $120.48 |
| Q1 2020 | -3,137 | Reduce 58.78% | 2,200 | $107.73 |
| Q2 2020 | -435 | Reduce 19.77% | 1,765 | $136.54 |
| Q3 2020 | +340 | Add 19.26% | 2,105 | $135.39 |
| Q4 2020 | +174 | Add 8.27% | 2,279 | $151.38 |
| Q1 2021 | -23 | Reduce 1.01% | 2,256 | $150.71 |
| Q2 2021 | +101 | Add 4.48% | 2,357 | $163.77 |
| Q3 2021 | -412 | Reduce 17.48% | 1,945 | $161.44 |
| Q4 2021 | +260 | Add 13.37% | 2,205 | $152.83 |
| Q1 2022 | +781 | Add 35.42% | 2,986 | $130.27 |
| Q2 2022 | -979 | Reduce 32.79% | 2,007 | $117.59 |
| Q3 2022 | -2,007 | Sold Out | 2,007 | $117.59 |
| Q4 2022 | +1,828 | New Buy | 1,828 | $131.29 |
| Q1 2023 | -5 | Reduce 0.27% | 1,823 | $129.17 |
| Q2 2023 | +199 | Add 10.92% | 2,022 | $126.99 |
| Q3 2023 | -331 | Reduce 16.37% | 1,691 | $122.32 |
| Q4 2023 | -1,691 | Sold Out | 1,691 | $122.32 |
| Q1 2024 | +3,148 | New Buy | 3,148 | $137.25 |
| Q2 2024 | -485 | Reduce 15.41% | 2,663 | $137.28 |
| Q3 2024 | -529 | Reduce 19.86% | 2,134 | $145.61 |
| Q4 2024 | +410 | Add 19.21% | 2,544 | $132.22 |
| Q1 2025 | -141 | Reduce 5.54% | 2,403 | $127.91 |
| Q2 2025 | -136 | Reduce 5.66% | 2,267 | $126.52 |
| Q3 2025 | -67 | Reduce 2.96% | 2,200 | $144.37 |
Ken Fisher's iShares Biotechnology ETF Investment FAQs
Ken Fisher first purchased iShares Biotechnology ETF (IBB) in Q3 2016, acquiring 1,417 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held iShares Biotechnology ETF (IBB) for 37 quarters since Q3 2016.
Ken Fisher's largest addition to iShares Biotechnology ETF (IBB) was in Q2 2019, adding 11,072 shares worth $1.21 M.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 2,200 shares of iShares Biotechnology ETF (IBB), valued at approximately $317,614.
As of the Q3 2025 filing, iShares Biotechnology ETF (IBB) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in iShares Biotechnology ETF (IBB) was 11,072 shares, as reported at the end of Q2 2019.